Celltrion
068270.KS
#656
Rank
โ‚น2.622 T
Marketcap
โ‚น12,663
Share price
0.25%
Change (1 day)
39.44%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Celltrion (068270.KS) - Total debt

Total debt on the balance sheet as of March 2024 : โ‚น135.21 B

According to Celltrion 's latest financial reports the company's total debt is โ‚น135.21 B. A companyโ€™s total debt is the sum of all current and non-current debts.

Celltrion - Total debt on balance sheet (from 2007 to 2024)

Total debt by year

Year Total debt Change
2022-12-31โ‚น51.99 B11.54%
2021-12-31โ‚น46.61 B-10.42%
2020-12-31โ‚น52.04 B70.67%
2019-12-31โ‚น30.49 B-5.27%
2018-12-31โ‚น32.18 B-16.15%
2017-12-31โ‚น38.38 B0.29%
2016-12-31โ‚น38.27 B-14.92%
2015-12-31โ‚น44.98 B-7.9%
2014-12-31โ‚น48.84 B11.19%
2013-12-31โ‚น43.93 B39.03%
2012-12-31โ‚น31.59 B66.13%
2011-12-31โ‚น19.02 B73.89%
2010-12-31โ‚น10.93 B8.71%
2009-12-31โ‚น10.06 B8.4%
2008-12-31โ‚น9.28 B699.8%
2007-12-31โ‚น1.16 B